NFKB1 and diffuse large B-cell lymphoma: For example, as a characteristic of activated B cell-like Diffuse large B-cell lymphoma (ABC DLBCL), constitutive activation of NF-κB signaling drives cancer cell proliferation/survival (167), which provides a shred of reasonable evidence for therapeutic strategies targeting IKKβ/NF-κB.